Determination of ischemic stroke onset time is critical in ischemic stroke treatment. 1H-MRSI has been recognized as a potentially powerful tool for noninvasive metabolic imaging, which showed great promise for the assessment of stroke onset time. This study investigated changes of neurometabolite concentrations in lesion after different symptom onset time in ischemic stroke patients using a fast high-resolution 3D MRSI technique. Our results showed that NAA concentration within the ischemic lesion decreased in a time-dependent manner after stroke onset, which might provide a useful metabolic biomarker for assessment of symptom onset time.
This abstract and the presentation materials are available to members only; a login is required.